Hacker News with Generative AI: Healthcare

One of Britain's largest health trusts says 'no ta' to Palantir data platform (theregister.com)
Greater Manchester Integrated Care Board (ICB) has decided not to adopt a national data platform – prescribed by the UK government and run by Palantir – until it has more evidence of the benefits and risks.
Launch HN: WorkDone (YC X25) – AI Audit of Medical Charts (ycombinator.com)
Hey HN! We’re Dmitry, Sergey, and Alex, co-founders of WorkDone. In one sentence: we built an AI product that audits medical documentation in real time to catch and fix errors before they turn into treatment mistakes or denied insurance claims.
UnitedHealth paid nursing homes to reduce hospital transfers (theguardian.com)
UnitedHealth Group, the nation’s largest healthcare conglomerate, has secretly paid nursing homes thousands in bonuses to help slash hospital transfers for ailing residents – part of a series of cost-cutting tactics that has saved the company millions, but at times risked residents’ health, a Guardian investigation has found.
NHS England hospitals cast doubt on Palantir use case (theregister.com)
English hospitals are voicing their concern about the functionality provided by Palantir, the US spy-tech firm that won a £330 million ($437 million) deal to run the Federated Data Platform for NHS England, as around a third of trusts go live on the system.
FDA announces change to future Covid-19 vaccine approvals (cnn.com)
23andMe Sells Gene-Testing Business to DNA Drug Maker Regeneron (bloomberg.com)
Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.
II-Medical – Edge MIT Licensed ChatGPT Level Medical AI (ii.inc)
Medical AI continues to advance at a rapid pace - and our II-Medical-8B is a testament to just how far we’ve come.
UK hospitals doubt Palantir utility: We'd 'lose functionality rather than gain' (theregister.com)
English hospitals are voicing their concern about the functionality provided by Palantir, the US spy-tech firm that won a £330 million ($437 million) deal to run the Federated Data Platform for NHS England, as around a third of trusts go live on the system.
NHS rolls out 5-minute 'super-jab' for 15 cancers (england.nhs.uk)
Thousands of patients will benefit from a new cancer jab for more than a dozen types of the disease, with the NHS the first in Europe to offer the new injection.
The first US hub for experimental medical treatments is coming (technologyreview.com)
Montana just passed a new bill backed by longevity enthusiasts that will enable access to drugs and therapies that are not approved by the FDA.
Palantir's NHS data platform rejected by most hospitals (democracyforsale.substack.com)
US doctors rewrite DNA of infant with genetic disorder in medical first (theguardian.com)
Doctors in the US have become the first to treat a baby with a customised gene-editing therapy after diagnosing the child with a severe genetic disorder that kills about half of those affected in early infancy.
California sent residents' personal health data to LinkedIn (themarkup.org)
The website that lets Californians shop for health insurance under the Affordable Care Act, coveredca.com, has been sending sensitive data to LinkedIn, forensic testing by The Markup has revealed.
The A.I. Radiologist Will Not Be with You Soon (nytimes.com)
Nine years ago, one of the world’s leading artificial intelligence scientists singled out an endangered occupational species.
'Inverse vaccines': promise of a 'holy grail' treatment for autoimmune diseases (theguardian.com)
Autoimmune diseases affect as many as 800 million people around the world – around one in 10 of us. From multiple sclerosis and lupus to type one diabetes and rheumatoid arthritis, these conditions all share a common trait: the body’s own immune system turns against itself.
Trump announces he'll sign executive order that aims to cut drug prices (cnn.com)
Elizabeth Holmes's partner raises millions for blood-testing startup (theguardian.com)
Elizabeth Holmes’s romantic partner – the father of her children – reportedly has raised millions of dollars to start up a new blood-testing company that is strikingly similar to the one that landed the Theranos founder in federal prison.
'It cannot provide nuance': UK experts warn AI therapy chatbots are not safe (theguardian.com)
Experts say such tools may give dangerous advice and more oversight is needed, as Mark Zuckerberg says AI can plug gap
mRNA vaccine makers are scrambling to navigate an 'existential threat' (nature.com)
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.
Digital Dinosaurs Supervising Medtech: Getting Audited by the Berlin Authorities (eidel.io)
At my company, we’ve had the questionable privilege to attend multiple audits of medical software manufacturers by the Berlin authorities. I’d like to share a few anecdotes. I’ll stick to the facts, and you can form your own opinion:
Aetna reimburses 25% less than what they claim (case study) (johnsonkevin.com)
tl;dr - Aetna says they’ll reimburse 140% of the “Medicare Allowable Rate” for out-of-network medical expenses. In my case they find that number and reduce it by 25%.
The Price of Remission (propublica.org)
When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me.
Will protein design tools solve the snake antivenom shortage? (owlposting.com)
There has been a fair bit of discussion over this recent ‘creating binders against snake venom protein’ paper from the Baker Lab that came out earlier this year, including this article from Derek Lowe.
Medical device maker Masimo warns of cyberattack, manufacturing delays (bleepingcomputer.com)
Medical device company Masimo Corporation warns that a cyberattack is impacting production operations and causing delays in fulfilling customers' orders.
'Biomedical Lab in a Box' empowers engineers in low- and middle-income countries (news.mit.edu)
Globally, and especially in low- and middle-income countries (LMICs), a significant portion of the population lacks access to essential health-care services.
A new hairlike electrode for long-term, high-quality EEG monitoring (psu.edu)
The future of electroencephalography (EEG) monitoring may soon look like a strand of hair.
UnitedHealth's Move to End Cyberattack Loan Lifeline Upsets Medical Providers (nytimes.com)
The company lent roughly $9 billion to practices affected by a vast cyberattack on its payment systems last year. Medical practices are now suing the health care colossus, saying it is pressuring them to repay funds.
U.S. State Autism Databases (resiliencymentalhealth.com)
I have written before about my decision not to offer autism evaluations in North Dakota because of a state law that requires me to put my clients on a government list, which is unethical.
EU prohibited paying for plasma – shortage met by buying plasma from US (dynomight.substack.com)
Examples are good. Let’s start with some examples:
The end of compounded GLP-1 drugs leaves many patients in a ‘lose-lose’ position (statnews.com)
The explosion of compounded GLP-1 offerings over the past two years is coming to an end, and many patients are left with no good options.